UK Department for International Trade

A number of companies shown here with profiles and logos are financially supported by the UK government's Tradeshow Access Programme.

Aptus Clinical Ltd

Aptus Clinical is a specialist UK- based oncology clinical research organisation which helps life science companies to optimise their clinical development strategies and effectively transform promising molecules into valued medicines.

What makes Aptus Clinical different is our flexibility – our clients benefit from our network of highly experienced and skilled experts from all technical disciplines, but only pay for what they need, when they need it. Our scientists have global expertise in all aspects of drug development so no challenge is too great, and being highly professional, they integrate seamlessly into a client organisation. This gives our clients all the benefits of an in-house clinical department, but at 
a significantly lower cost. In addition, our well-established relationships with some of the world’s leading experimental cancer centres, access to large patient populations and flexible arrangements to support optimal project delivery are just a few of the benefits to be gained from working with Aptus Clinical.

Company type
Dr Steve McConchie
CEO 

Biorelate Limited

Company type
Dr Daniel Jamieson
CEO & Founder 
Mr Nick Sullivan
Head of Commercial 

Boyds Consultants Ltd

Prof Alan Boyd
CEO 
Dr Julie Warner
Director, Regulatory Affairs 
Ms Siobhan Gaynor
Director, Business Development and Boyds Ireland 

Bridgehead

Company type
Dr Laurence Callow
Chief Executive 

CIMYM BioSciences Ltd

CIMYM BioSciences was established to develop oncology and immunological therapeutics.  At CIMYM we believe passionately that drug development can only be successful if it is patient centred; ‘Begin with the patient in mind…’ As a healthcare company we recognise an exceptional idea to fill a medical need, build a network and then establish a clinical utility that will improve patient care.  CIMYM uses its expertise to manage value-enhancing activities in the development process of pharmaceuticals and diagnostics. It takes a patient-centred approach to co-develop innovative products and in turn licenses the rights for manufacture and marketing to other pharmaceutical companies for license fees and royalty payments.
Company type
Ms Yvonne Joseph
Managing Director 
Mr Andrew Mackie
Corporate Development 

Closed Loop Medicine

Dr Hakim Yadi
CEO 

Foothold America (Alacrita)

Company type
Keywords
Ms Joanne Farquharson
Global General Manager 

Kaleidoscope Consultants Limited

Kaleidoscope Consultants are subject matter experts in information law, privacy and regulatory policy in health and social care. We provide expert advice on strategies to enable data exchanges, and development of national guidance for public and private sector organisations on the lawful use of Personal Confidential Data. We have in-depth knowledge of all aspects of the lawful utilisation and sharing of Personal Confidential Data and have created lean and robust governance approaches and systems that provide effective technical and organisational control.
Mr David Stone
Managing Director 

LSX Ltd

Mr Matthew Pullan
Senior Vice President 
Mr Tom Roberts
Vice President